These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 29493854)

  • 21. Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006.
    Béjot Y; Ben Salem D; Osseby GV; Couvreur G; Durier J; Marie C; Cottin Y; Moreau T; Giroud M
    Neurology; 2009 Jan; 72(4):346-53. PubMed ID: 19171832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial and ethnic differences in the prevalence, management, and outcomes in patients with atrial fibrillation: A systematic review.
    Ugowe FE; Jackson LR; Thomas KL
    Heart Rhythm; 2018 Sep; 15(9):1337-1345. PubMed ID: 29803022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stroke prevention in atrial fibrillation patients in Poland and other European countries: insights from the GARFIELD-AF registry.
    Stępińska J; Kremis E; Konopka A; Wożakowska-Kapłon B; Ruszkowski P; Kukla P; Kayani G
    Kardiol Pol; 2016; 74(4):362-71. PubMed ID: 26365937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial fibrillation in the Middle East: unmapped, underdiagnosed, undertreated.
    Al-Shamkhani W; Ayetey H; Lip GYH
    Expert Rev Cardiovasc Ther; 2018 May; 16(5):341-348. PubMed ID: 29575965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thromboembolism in patients with nonvalvular atrial fibrillation: comparison between Asian and Western countries.
    Inoue H
    J Cardiol; 2013 Jan; 61(1):1-7. PubMed ID: 23068291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence, incidence, risk factors and treatment of atrial fibrillation in Australia: The Australian Diabetes, Obesity and Lifestyle (AusDiab) longitudinal, population cohort study.
    Diouf I; Magliano DJ; Carrington MJ; Stewart S; Shaw JE
    Int J Cardiol; 2016 Feb; 205():127-132. PubMed ID: 26730844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis.
    Zimmerman D; Sood MM; Rigatto C; Holden RM; Hiremath S; Clase CM
    Nephrol Dial Transplant; 2012 Oct; 27(10):3816-22. PubMed ID: 23114904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global and regional burden of ischemic stroke associated with atrial fibrillation, 2009-2019.
    Hewage S; Jadamba A; Brain D; Parsonage W; McPhail S; Kularatna S
    Prev Med; 2023 Aug; 173():107584. PubMed ID: 37348767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial fibrillation and silent stroke: links, risks, and challenges.
    Hahne K; Mönnig G; Samol A
    Vasc Health Risk Manag; 2016; 12():65-74. PubMed ID: 27022272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke: Results from a national stroke screening survey.
    Wang X; Fu Q; Song F; Li W; Yin X; Yue W; Yan F; Zhang H; Zhang H; Teng Z; Wang L; Gong Y; Wang Z; Lu Z
    Int J Cardiol; 2018 Nov; 271():92-97. PubMed ID: 29885822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stroke with atrial fibrillation or atrial flutter: a descriptive population-based study from the Brest stroke registry.
    Jannou V; Timsit S; Nowak E; Rouhart F; Goas P; Merrien FM; Viakhireva-Dovganyuk I; Tirel-Badets A; Gentric A
    BMC Geriatr; 2015 Jun; 15():63. PubMed ID: 26062790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial fibrillation in immigrant groups: a cohort study of all adults 45 years of age and older in Sweden.
    Wändell P; Carlsson AC; Li X; Gasevic D; Ärnlöv J; Holzmann MJ; Sundquist J; Sundquist K
    Eur J Epidemiol; 2017 Sep; 32(9):785-796. PubMed ID: 28702880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Characteristics and Outcomes in Extreme Elderly (Age ≥ 85 Years) Japanese Patients With Atrial Fibrillation: The Fushimi AF Registry.
    Yamashita Y; Hamatani Y; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GYH; Akao M
    Chest; 2016 Feb; 149(2):401-412. PubMed ID: 26181726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Atrial fibrillation and stroke].
    Mattle HP; Schwerzmann M; Seiler Ch
    Ther Umsch; 2003 Sep; 60(9):527-34. PubMed ID: 14579621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation: The Fushimi Atrial Fibrillation Registry.
    Takabayashi K; Hamatani Y; Yamashita Y; Takagi D; Unoki T; Ishii M; Iguchi M; Masunaga N; Ogawa H; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GY; Akao M
    Stroke; 2015 Dec; 46(12):3354-61. PubMed ID: 26514188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA
    Lee SR; Choi EK; Han KD; Cha MJ; Oh S
    Int J Cardiol; 2017 Jun; 236():226-231. PubMed ID: 28233629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries.
    Steinberg BA; Gao H; Shrader P; Pieper K; Thomas L; Camm AJ; Ezekowitz MD; Fonarow GC; Gersh BJ; Goldhaber S; Haas S; Hacke W; Kowey PR; Ansell J; Mahaffey KW; Naccarelli G; Reiffel JA; Turpie A; Verheugt F; Piccini JP; Kakkar A; Peterson ED; Fox KAA; ;
    Am Heart J; 2017 Dec; 194():132-140. PubMed ID: 29223431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
    Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stroke and Embolic Events in Hypertrophic Cardiomyopathy: Risk Stratification in Patients Without Atrial Fibrillation.
    Haruki S; Minami Y; Hagiwara N
    Stroke; 2016 Apr; 47(4):936-42. PubMed ID: 26941260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.